Capital Analysts, LLC Zoetis Inc. Transaction History

Capital Analysts, LLC

$2.45 Billion
Q3 2024

A detailed history of Capital Analysts, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Capital Analysts, LLC holds 54,688 shares of ZTS stock, worth $9.58 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

54,688

Previous 54,495 0.35%

Holding current value

$9.58 Million

Previous $9.45 Million 13.1%

% of portfolio

0.44%

Previous 0.42%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$172.58 - $196.48 $33,307 - $37,920	193 Added 0.35%	54,688 $10.7 Million
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $370,690 - $455,480	2,547 Added 4.9%	54,495 $9.45 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $102,052 - $123,163	616 Added 1.2%	51,948 $8.79 Million
Q4 2023 Jan 30, 2024	BUY	$151.44 - $200.09 $111,914 - $147,866	739 Added 1.46%	51,332 $10.1 Million
Q3 2023 Nov 13, 2023	BUY	$167.14 - $192.77 $506,267 - $583,900	3,029 Added 6.37%	50,593 $8.8 Million
Q2 2023 Aug 11, 2023	BUY	$160.94 - $186.23 $370,322 - $428,515	2,301 Added 5.08%	47,564 $8.19 Million
Q1 2023 May 05, 2023	BUY	$145.48 - $175.02 $257,499 - $309,785	1,770 Added 4.07%	45,263 $7.53 Million
Q4 2022 Feb 08, 2023	BUY	$131.14 - $157.47 $390,666 - $469,103	2,979 Added 7.35%	43,493 $6.37 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $374,432 - $460,938	2,525 Added 6.65%	40,514 $6.01 Million
Q2 2022 Aug 12, 2022	BUY	$155.97 - $200.09 $247,212 - $317,142	1,585 Added 4.35%	37,989 $6.53 Million
Q1 2022 May 12, 2022	BUY	$181.39 - $234.03 $238,709 - $307,983	1,316 Added 3.75%	36,404 $6.87 Million
Q4 2021 Feb 10, 2022	SELL	$193.69 - $247.03 $22,661 - $28,902	-117 Reduced 0.33%	35,088 $8.56 Million
Q3 2021 Nov 04, 2021	BUY	$189.29 - $209.69 $19,875 - $22,017	105 Added 0.3%	35,205 $6.83 Million
Q2 2021 Nov 15, 2021	SELL	$155.9 - $187.99 $5,612 - $6,767	-36 Reduced 0.1%	35,100 $6.54 Million
Q2 2021 Aug 05, 2021	BUY	$155.9 - $187.99 $197,681 - $238,371	1,268 Added 3.74%	35,136 $6.55 Million
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $108,432 - $127,550	-753 Reduced 2.17%	33,868 $5.33 Million
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $35,340 - $39,228	225 Added 0.65%	34,621 $5.73 Million
Q3 2020 Nov 12, 2020	SELL	$137.1 - $165.37 $167,262 - $201,751	-1,220 Reduced 3.43%	34,396 $5.69 Million
Q2 2020 Aug 07, 2020	SELL	$111.92 - $142.53 $216,117 - $275,225	-1,931 Reduced 5.14%	35,616 $4.88 Million
Q1 2020 May 08, 2020	SELL	$92.66 - $144.94 $14,547 - $22,755	-157 Reduced 0.42%	37,547 $4.42 Million
Q4 2019 Feb 12, 2020	SELL	$116.25 - $133.25 $85,327 - $97,805	-734 Reduced 1.91%	37,704 $4.99 Million
Q3 2019 Nov 12, 2019	SELL	$112.57 - $128.43 $33,658 - $38,400	-299 Reduced 0.77%	38,438 $4.79 Million
Q2 2019 Aug 13, 2019	SELL	$97.98 - $114.28 $225,354 - $262,844	-2,300 Reduced 5.6%	38,737 $4.4 Million
Q1 2019 May 13, 2019	BUY	$81.56 - $100.67 $3.35 Million - $4.13 Million	41,037 New	41,037 $4.13 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Zoetis Inc. Transaction History